Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1344 ARTÍCULOS , VIENDO DEL 1 AL 15

Psychotropic drug effects on gene transcriptomics relevant to Alzheimer disease

Lauterbach EC.

Alzheimer Dis Assoc Disord. 2012 Jan-Mar;26(1):1-7. doi: 10.1097/WAD.0b013e318214b7d0.

γ-Secretase, apolipoprotein E and cellular cholesterol metabolism

Walter J.

Curr Alzheimer Res. 2012 Feb;9(2):189-99. doi: 10.2174/156720512799361583.

α-Secretase in Alzheimer's disease and beyond: mechanistic, regulation and function in the shedding of membrane proteins

Vincent B, Checler F.

Curr Alzheimer Res. 2012 Feb;9(2):140-56. doi: 10.2174/156720512799361646.

AICD nuclear signaling and its possible contribution to Alzheimer's disease

Konietzko U.

Curr Alzheimer Res. 2012 Feb;9(2):200-16. doi: 10.2174/156720512799361673.

The Role of the anti-amyloidogenic secretase ADAM10 in shedding the APP-like proteins

Endres K, Fahrenholz F.

Curr Alzheimer Res. 2012 Feb;9(2):157-64. doi: 10.2174/156720512799361664.

The role for oxidative stress in aberrant DNA methylation in Alzheimer's disease

Fleming JL, Phiel CJ, Toland AE.

Curr Alzheimer Res. 2012 Nov;9(9):1077-96. doi: 10.2174/156720512803569000.

Caprospinol: discovery of a steroid drug candidate to treat Alzheimer's disease based on 22R-hydroxycholesterol structure and properties

Papadopoulos V, Lecanu L.

J Neuroendocrinol. 2012 Jan;24(1):93-101. doi: 10.1111/j.1365-2826.2011.02167.x.

Strategies, development, and pitfalls of therapeutic options for Alzheimer's disease

Haas C.

J Alzheimers Dis. 2012;28(2):241-81. doi: 10.3233/JAD-2011-110986.

Breakpoint sequence analysis of an AβPP locus duplication associated with autosomal dominant Alzheimer's disease and severe cerebral amyloid angiopathy

Antonell A, Gelpi E, Sánchez-Valle R, Martínez R, Molinuevo JL, Lladó A.

J Alzheimers Dis. 2012;28(2):303-8. doi: 10.3233/JAD-2011-110911.

Apolipoprotein ε4 modulates phenotype of butyrylcholinesterase in CSF of patients with Alzheimer's disease

Darreh-Shori T, Siawesh M, Mousavi M, Andreasen N, Nordberg A.

J Alzheimers Dis. 2012;28(2):443-58. doi: 10.3233/JAD-2011-111088.

Antioxidative strategies in cognitive impairment: a novel connection between biliverdin-reductase and statins

Schneider A, Simons M.

J Neurochem. 2012 Jan;120(1):1-3. doi: 10.1111/j.1471-4159.2011.07548.x.

β-Apptists and Tauists, it is time for a sermon from the book of biogenesis

Swerdlow RH.

J Neurochem. 2012 Feb;120(3):347-9. doi: 10.1111/j.1471-4159.2011.07561.x.

New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs

Salomone S, Caraci F, Leggio GM, Fedotova J, Drago F.

Br J Clin Pharmacol. 2012 Apr;73(4):504-17. doi: 10.1111/j.1365-2125.2011.04134.x.

Association of SORL1 alleles with late-onset Alzheimer's disease. findings from the GIGAS_LOAD study and mega-analysis

Olgiati P, Politis A, Albani D, Rodilossi S, Polito L, Ateri E, Zisaki A, Piperi C, Liappas I, Stamouli E, Mailis A, Atti AR, Ferrari B, Morini V, Moretti F, Biella G, Forloni G, Papadimitriou GN, Ronchi DD, Kalofoutis A, Serretti A.

Curr Alzheimer Res. 2012 May;9(4):491-9. doi: 10.2174/156720512800492431.

Tau-targeted treatment strategies in Alzheimer's disease

Götz J, Ittner A, Ittner LM.

Br J Pharmacol. 2012 Mar;165(5):1246-59. doi: 10.1111/j.1476-5381.2011.01713.x.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias